These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28514765)

  • 1. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Li Y; Cui N; Zheng PS; Yang WT
    Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.
    Feng T; Zheng L; Liu F; Xu X; Mao S; Wang X; Liu J; Lu Y; Zhao W; Yu X; Tang W
    Oncotarget; 2016 Sep; 7(36):58381-58395. PubMed ID: 27517315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
    Lu R; Yang Z; Xu G; Yu S
    Biomed Pharmacother; 2018 Sep; 105():633-644. PubMed ID: 29898430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
    Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.
    Zhang L; Huo X; Liao Y; Yang F; Gao L; Cao L
    Sci Rep; 2017 May; 7(1):1669. PubMed ID: 28490807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
    Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
    Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2.
    Li S; Ma YM; Zheng PS; Zhang P
    J Exp Clin Cancer Res; 2018 Apr; 37(1):80. PubMed ID: 29636108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
    Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP
    Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
    Zhang Y; Li G; Ji C
    J BUON; 2018; 23(6):1739-1744. PubMed ID: 30610802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
    Bai X; Ma Y; Zhang G
    Oncol Rep; 2015 Jun; 33(6):3085-92. PubMed ID: 25962638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation of cervical cancer growth and invasion by VEGFa.
    Chen B; Zhang C; Dong P; Guo Y; Mu N
    Tumour Biol; 2014 Nov; 35(11):11587-93. PubMed ID: 25135429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans.
    Zhang X; Fu LJ; Liu XQ; Hu ZY; Jiang Y; Gao RF; Feng Q; Lan X; Geng YQ; Chen XM; He JL; Wang YX; Ding YB
    Hum Reprod; 2016 Oct; 31(10):2339-51. PubMed ID: 27604954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
    Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
    Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.